BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Caitlin Cronin does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 ENOVEnovis Corp | Buy | $70.00 | May 2025 | −40.1% | Miss |
 AXGNAxogen Inc | Buy | $24.00 | May 2025 | +224.9% | Hit |
 TELATela Bio Inc | Buy | $7.00 | Mar 2025 | −40.9% | Miss |
 BVSBioventus Inc | Buy | $15.00 | Mar 2025 | −9.7% | Miss |
| AXGNAxogen Inc | Buy | $26.00 | Feb 2025 | +55.4% | Hit |
 VCELVericel Corp Ord | Buy | $67.00 | Feb 2025 | −44.2% | Miss |
| AXGNAxogen Inc | Buy | $22.00 | Feb 2025 | +88.1% | Hit |
| VCELVericel Corp Ord | Buy | $60.00 | Nov 2024 | −40.5% | Hit |
 KRMDRepro Med Systems Inc | Buy | $4.00 | Nov 2024 | +27.3% | Hit |
| TELATela Bio Inc | Buy | $12.00 | Oct 2024 | −39.3% | Miss |
| TELATela Bio Inc | Buy | $12.00 | Aug 2024 | −41.0% | Miss |
| VCELVericel Corp Ord | Buy | $57.00 | Aug 2024 | −10.7% | Hit |
| TELATela Bio Inc | Buy | $14.00 | Jul 2024 | −50.8% | Miss |
| AXGNAxogen Inc | Buy | $15.00 | Jun 2024 | +47.2% | Hit |
| KRMDRepro Med Systems Inc | Buy | $3.00 | Dec 2023 | +48.4% | Hit |
| AXGNAxogen Inc | Buy | $11.00 | Dec 2023 | +87.6% | Hit |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.